Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Ana Babić

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1199-5958; OpenAlex author ID A5028918814; NIH RePORTER profile ID 11936213. Sources: OpenAlex.

Their work

Papers
41 (first author 2, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
111
Papers, trials and grants by year

2016: 3 papers · 2017: 3 papers · 2018: 8 papers · 2019: 5 papers · 2020: 8 papers · 2021: 4 papers · 2022: 1 paper, 1 grant · 2023: 6 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 41

  1. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  2. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  3. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Co-author DOI 10.1136/gutjnl-2023-331074↗
  4. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2023.101194↗
  5. Pancreatic cancer is associated with medication changes prior to clinical diagnosis. Co-author DOI 10.1038/s41467-023-38088-2↗
  6. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Co-author DOI 10.1038/s41467-023-40024-3↗
  7. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  8. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-23-0505↗
  9. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Co-author DOI 10.14309/ctg.0000000000000573↗
  10. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  11. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Co-author DOI 10.1053/j.gastro.2020.11.052↗
  12. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  13. Prediagnostic Inflammation and Pancreatic Cancer Survival. Last author DOI 10.1093/jnci/djab040↗
  14. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  15. Diabetes, Weight Change, and Pancreatic Cancer Risk. First author DOI 10.1001/jamaoncol.2020.2948↗
  16. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.cell.2020.03.062↗
  17. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  18. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  19. Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1055-9965.epi-19-1315↗
  20. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  21. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  22. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  23. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Co-author DOI 10.1038/s41416-019-0426-5↗
  24. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  25. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma Co-author DOI 10.1101/663583↗
  26. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0370↗
  27. Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-19-0577↗
  28. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2017.3420↗
  29. Statin use and pancreatic cancer risk in two prospective cohort studies. Co-author DOI 10.1007/s00535-018-1430-x↗
  30. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.02.022↗
  31. Plasma inflammatory cytokines and survival of pancreatic cancer patients. Co-author DOI 10.1038/s41424-018-0008-5↗
  32. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  33. Altered exocrine function can drive adipose wasting in early pancreatic cancer. First author DOI 10.1038/s41586-018-0235-7↗
  34. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studie… Co-author DOI 10.1053/j.gastro.2017.12.001↗
  35. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Co-author DOI 10.1158/2159-8290.cd-18-0275↗
  36. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Co-author DOI 10.1038/bjc.2017.349↗
  37. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-312510↗
  38. Cigarette Smoking and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2016.71.2026↗
  39. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Co-author DOI 10.1158/0008-5472.can-16-1699↗
  40. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2015.66.3005↗
  41. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker? Co-author DOI 10.1373/clinchem.2015.246538↗

Grants 1

  1. Obesity and Pancreatic Cancer Progression and Survival K07CA222159↗

Closest collaborators

The 25 strongest of 111 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian Matthew Wolpin · 29 shared papers, 2016–2024 · strength 2.47
  2. Kimmie Ng · 25 shared papers, 2016–2024 · strength 2.14
  3. Chen Yuan · 23 shared papers, 2016–2024 · strength 1.91
  4. Charles S. Fuchs · 20 shared papers, 2016–2023 · strength 1.48
  5. Edward L. Giovannucci · 16 shared papers, 2016–2023 · strength 1.35
  6. Peter Kraft · 16 shared papers, 2016–2023 · strength 1.35
  7. Jonathan Andrew Nowak · 14 shared papers, 2017–2024 · strength 1.25
  8. Vicente Morales‐Oyarvide · 15 shared papers, 2016–2021 · strength 0.95
  9. Natalia I. Khalaf · 11 shared papers, 2017–2023 · strength 0.84
  10. JoAnn E. Manson · 10 shared papers, 2016–2023 · strength 0.80
  11. Qiao-Li Wang Wang · 6 shared papers, 2022–2024 · strength 0.79
  12. Douglas Adam Rubinson · 11 shared papers, 2016–2024 · strength 0.77
  13. Alice A. Lee · 5 shared papers, 2022–2023 · strength 0.66
  14. Kimberly J. Perez · 6 shared papers, 2019–2023 · strength 0.65
  15. Thomas E. Clancy · 6 shared papers, 2017–2024 · strength 0.53
  16. Michael Hayden Rosenthal · 5 shared papers, 2018–2023 · strength 0.50
  17. Andrew J. Aguirre · 5 shared papers, 2018–2024 · strength 0.48
  18. Andrea J. Bullock · 5 shared papers, 2017–2024 · strength 0.45
  19. Tsuyoshi Hamada · 6 shared papers, 2018–2020 · strength 0.43
  20. Zhi Rong Qian · 8 shared papers, 2016–2018 · strength 0.43
  21. Richard Francis Dunne · 6 shared papers, 2017–2020 · strength 0.39
  22. Albert C. Koong · 6 shared papers, 2017–2020 · strength 0.37
  23. Jihye Kim · 3 shared papers, 2020–2023 · strength 0.36
  24. Ehsan Irajizad · 3 shared papers, 2021–2024 · strength 0.35
  25. Michael D. Kluger · 3 shared papers, 2021–2024 · strength 0.35

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.